By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TRANSGENE S.A. 

11 rue de MOLSHEIM, 67082
Strasbourg
Cedex      France
Phone: 011-33-3-88-27-91-21 Fax: 011-33-3-88-27-91-11


SEARCH JOBS


Industry
Biotechnology

Segment
Gene Therapy

Collaborations

Human Genome Sciences, Inc.  Gene Therapy Partnerships





Company News
TRANSGENE (ENX:TNG) Announces Participation At Upcoming Investor Events 5/18/2015 11:50:56 AM
TRANSGENE (ENX:TNG) Presents New Data With TG1050, An Immunotherapy Being Developed To Treat Chronic Hepatitis B, At The International Liver Congress 2015 4/23/2015 11:25:17 AM
TRANSGENE (ENX:TNG) Reports First Quarter 2015 Financial Results 4/22/2015 11:25:39 AM
TRANSGENE (ENX:TNG) Presents New Pre-Clinical Data At AACR On (I) The Combination Of TG4010 With Immune Checkpoint Inhibitors; (Ii) TG3003, An Anti-CD115 Monoclonal Antibody 4/21/2015 11:47:14 AM
TRANSGENE (ENX:TNG): Agreement With FDA Announced For Special Protocol Assessment For Upcoming Phase 3 Pexa-Vec Trial In Advanced Liver Cancer 4/16/2015 10:14:10 AM
TRANSGENE (ENX:TNG) Reports 2014 Financial Results And Outlines Promising Clinical Pipeline 3/25/2015 9:53:06 AM
TRANSGENE (ENX:TNG) Announces New Pre-Clinical Data With TG4010 In Combination With Immune Checkpoint Inhibitors And TG3003 (Humanized Mab Anti-CD115) To Be Presented At American Association for Cancer Research 3/19/2015 12:52:59 PM
TRANSGENE (ENX:TNG) Announces Financial Calendar For 2015 1/8/2015 10:51:20 AM
TRANSGENE (ENX:TNG) Announces Events Calendar For Fourth Quarter 2014 10/29/2014 8:56:35 AM
TRANSGENE (ENX:TNG) Announces Third Quarter 2014 Financial Results 10/22/2014 9:36:46 AM
12345678910...
//-->